{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T06:18:27Z","timestamp":1778825907767,"version":"3.51.4"},"reference-count":21,"publisher":"Academia.edu Journals","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p xml:lang=\"en\">Background: Patients with Inflammatory bowel disease (IBD) often seek alternative therapies for symptom management. This study investigates the perceptions, consumption patterns, and reported outcomes of cannabis and cannabidiol (CBD) oil use among IBD patients and controls. Methods: A 37-question survey was administered to 139 participants (IBD patients, n = 93; control\/non-IBD participants, n = 33) to assess usage frequency and beliefs regarding cannabis and CBD oil as treatment for IBD. The survey also evaluated the impact of these substances on IBD symptoms, quality of life, and opioid use. Results: Cannabis consumption was higher in IBD patients (57, 53.8%) than controls (15, 45.5%) with both groups strongly supporting medical cannabis use (IBD; 92, 86.8% vs. controls; 29, 84.9%). Most IBD patients believed cannabis (67, 63.2%), CBD oil (60, 56.6%), corticosteroids (77, 73.3%), and biologics\/immunosuppressants (85, 81.0%) had a somewhat-extremely beneficial effect in relieving IBD symptoms. Over 50% of IBD cannabis users reported relief from abdominal pain, other pain, stress, anxiety, depression, and nausea\/vomiting, with Crohn\u2019s disease patients experiencing significantly more relief than ulcerative colitis patients for certain symptoms (p &lt; 0.05). Notably, 19.4% of IBD patients reported decreased opioid use, and 14.5% reported induced remission with cannabis or CBD oil. Conclusions: Consumption of cannabis and CBD oil was perceived as beneficial for relieving IBD, with many reporting significant symptom relief from using these substances. The strong support of cannabis and CBD oil as medical treatments and therapeutic effects highlights the potential for cannabis and CBD oil as treatments in IBD.<\/jats:p>","DOI":"10.20935\/acadmed7773","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T14:43:16Z","timestamp":1750171396000},"source":"Crossref","is-referenced-by-count":2,"title":["Inflammatory bowel disease patients believe cannabis and cannabidiol oil relieve symptoms"],"prefix":"10.20935","volume":"2","author":[{"given":"Ayati","family":"Lala","sequence":"first","affiliation":[{"name":"Department of Neurosciences, Case Western Reserve University, Cleveland, OH 44106, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Rodriguez-Palacios","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Liver Diseases, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA."},{"name":"Digestive Health Research Institute, University Hospitals Cleveland Medical Center, Cleveland, OH 44106, USA."},{"name":"Mouse Models, Silvio O\u2019Conte Cleveland Digestive Diseases Research Core Center, Cleveland, OH 44106, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Cominelli","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Liver Diseases, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA."},{"name":"Digestive Health Research Institute, University Hospitals Cleveland Medical Center, Cleveland, OH 44106, USA."},{"name":"Mouse Models, Silvio O\u2019Conte Cleveland Digestive Diseases Research Core Center, Cleveland, OH 44106, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abigail","family":"Raffner Basson","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Liver Diseases, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA."},{"name":"Digestive Health Research Institute, University Hospitals Cleveland Medical Center, Cleveland, OH 44106, USA."},{"name":"Department of Nutrition, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"9563","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"key":"B1-Acad.Med.-2-301511","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.3748\/wjg.v22.i3.1304","article-title":"Antibody markers in the diagnosis of inflammatory bowel disease","volume":"22","author":"Mitsuyama","year":"2016","journal-title":"World J Gastroenterol"},{"key":"B2-Acad.Med.-2-301511","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.bcp.2013.01.017","article-title":"Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease","volume":"85","author":"Borrelli","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"B3-Acad.Med.-2-301511","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.tips.2015.02.008","article-title":"Endocannabinoid signaling at the periphery: 50 years after THC","volume":"36","author":"Maccarrone","year":"2015","journal-title":"Trends Pharmacol Sci"},{"key":"B4-Acad.Med.-2-301511","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cgh.2013.04.034","article-title":"Cannabis induces a clinical response in patients with Crohn\u2019s disease: a prospective placebo-controlled study","volume":"11","author":"Naftali","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B5-Acad.Med.-2-301511","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/ibd\/izy319","article-title":"The Role of Cannabis in the Management of Inflammatory Bowel Disease: A Review of Clinical, Scientific, and Regulatory Information","volume":"25","author":"Swaminath","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"B6-Acad.Med.-2-301511","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.bpsc.2020.11.016","article-title":"Review of the Endocannabinoid System","volume":"6","author":"Lu","year":"2021","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"B7-Acad.Med.-2-301511","doi-asserted-by":"publisher","first-page":"Cd012853","DOI":"10.1002\/14651858.CD012853.pub2","article-title":"Cannabis for the treatment of Crohn\u2019s disease","volume":"11","author":"Kafil","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"B8-Acad.Med.-2-301511","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1097\/01.MIB.0000440982.79036.d6","article-title":"Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn\u2019s disease","volume":"20","author":"Storr","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"B9-Acad.Med.-2-301511","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1097\/01.MIB.0000435851.94391.37","article-title":"Marijuana use patterns among patients with inflammatory bowel disease","volume":"19","author":"Ravikoff Allegretti","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"B10-Acad.Med.-2-301511","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1097\/MEG.0b013e328349bb4c","article-title":"Cannabis use amongst patients with inflammatory bowel disease","volume":"23","author":"Lal","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B11-Acad.Med.-2-301511","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1111\/nmo.12931","article-title":"The gastrointestinal tract\u2014a central organ of cannabinoid signaling in health and disease","volume":"28","author":"Hasenoehrl","year":"2016","journal-title":"Neurogastroenterol Motil"},{"key":"B12-Acad.Med.-2-301511","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1136\/gutjnl-2014-307016","article-title":"Treatment of Crohn\u2019s disease with cannabis: an observational study","volume":"13","author":"Naftali","year":"2011","journal-title":"Isr Med Assoc J"},{"key":"B13-Acad.Med.-2-301511","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph20065129","article-title":"A survey of cannabis use among patients with inflammatory bowel disease (IBD)","volume":"20","author":"Velez-Santiago","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"B14-Acad.Med.-2-301511","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1093\/ibd\/izx002","article-title":"A randomized, double-blind, placebo-controlled, parallel-group, pilot study of cannabidiol-rich botanical extract in the symptomatic treatment of ulcerative colitis","volume":"24","author":"Irving","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"B15-Acad.Med.-2-301511","doi-asserted-by":"publisher","first-page":"309","DOI":"10.31887\/DCNS.2017.19.3\/glafaye","article-title":"Cannabis, cannabinoids, and health","volume":"19","author":"Lafaye","year":"2017","journal-title":"Dialogues Clin Neurosci"},{"key":"B16-Acad.Med.-2-301511","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0246871","article-title":"Cannabis is associated with clinical but not endoscopic remission in ulcerative colitis: a randomized controlled trial","volume":"16","author":"Naftali","year":"2021","journal-title":"PLoS ONE"},{"key":"B17-Acad.Med.-2-301511","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.gastrohep.2016.10.005","article-title":"Therapeutic use of cannabis in inflammatory bowel disease","volume":"12","author":"Ahmed","year":"2016","journal-title":"Gastroenterol Hepatol"},{"key":"B18-Acad.Med.-2-301511","doi-asserted-by":"publisher","DOI":"10.3390\/cells13191618","article-title":"The modulatory effects and therapeutic potential of cannabidiol in the gut","volume":"13","author":"Brown","year":"2024","journal-title":"Cells"},{"key":"B19-Acad.Med.-2-301511","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1080\/17474124.2024.2443574","article-title":"UK medical cannabis registry: an updated analysis of clinical outcomes of cannabis-based medicinal products for inflammatory bowel disease","volume":"18","author":"Gupta","year":"2024","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"B20-Acad.Med.-2-301511","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1093\/ibd\/izae158","article-title":"Meta-analysis of the therapeutic impact of cannabinoids in inflammatory bowel disease","volume":"31","author":"Kang","year":"2025","journal-title":"Inflamm Bowel Dis"},{"key":"B21-Acad.Med.-2-301511","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60122059","article-title":"The perceived effectiveness of cannabidiol on adult women with inflammatory bowel disease","volume":"60","author":"Portman","year":"2024","journal-title":"Medicina"}],"container-title":["Academia Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.academia.edu\/130008644\/Inflammatory_bowel_disease_patients_believe_cannabis_and_cannabidiol_oil_relieve_symptoms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T14:43:17Z","timestamp":1750171397000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.academia.edu\/130008644\/Inflammatory_bowel_disease_patients_believe_cannabis_and_cannabidiol_oil_relieve_symptoms"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":21,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,6]]}},"URL":"https:\/\/doi.org\/10.20935\/acadmed7773","relation":{},"ISSN":["2994-435X"],"issn-type":[{"value":"2994-435X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,17]]}}}